Beta Nerve Growth Factor
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
AC-253
DACRA-042
DACRA-089
KBP-056
KBP-088
Others
Segment by Application
Metabolic Disorders
Gastrointestinal
Musculoskeletal Disorders
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Adocia SAS
AstraZeneca Plc
Eli Lilly and Co
Neurimmune Holding AG
Nordic Bioscience A/S
Prothena Corp Plc
reMYND NV
Zealand Pharma AS
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More